These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3390658)

  • 1. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
    Hill BT; Whelan RD
    Cancer Chemother Pharmacol; 1982; 8(2):163-9. PubMed ID: 7105380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
    Tolis C; Photiou A; Camplejohn RS; Retsas S
    Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D; Schmidt H
    Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
    Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.
    Attaoua C; Vincent LA; Abdel Jaoued A; Hadj-Kaddour K; Baï Q; De Vos J; Vian L; Cuq P
    Fundam Clin Pharmacol; 2015 Feb; 29(1):62-71. PubMed ID: 25283245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cell cholesterol in modulating vincristine uptake and resistance.
    Pallarés-Trujillo J; Domènech C; Grau-Oliete MR; Rivera-Fillat MP
    Int J Cancer; 1993 Oct; 55(4):667-71. PubMed ID: 8406997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
    Safa AR; Glover CJ; Felsted RL
    Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.
    Smeland E; Bremnes RM; Bessesen A; Jaeger R; Aarbakke J
    Cancer Chemother Pharmacol; 1993; 32(3):209-14. PubMed ID: 8500226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1990 Sep; 265(27):16509-13. PubMed ID: 1975813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines.
    Photiou A; Sheikh MN; Bafaloukos D; Retsas S
    J Cancer Res Clin Oncol; 1992; 118(4):249-54. PubMed ID: 1577845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
    Leonce S; Anstett M; Combe-Perez V; Pierre A
    Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.